Electrical Stimulation for the Treatment of Optic Neuropathies

Part of paid clinical trials in Palo Alto, California.

Sponsor
Stanford University
Study ID
NCT05626426
Status
Recruiting
Apply to this trial

Conditions

  • Glaucoma
  • Glaucoma, Open-Angle
  • Optic Nerve Diseases

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Repetitive, Transorbital Alternating Current Stimulation (rtACS) — DEVICE
    Patients receive treatment every other day via a headband that delivers electrical stimulation to the retina

Study Details

The overall aim of this study is to see whether long-term electrical stimulation with a home-stimulation device works well and is safe for the treatment of open-angle glaucoma. Open-Angle Glaucoma is a disease where the nerves in the back of your eye die off faster than expected regardless of your eye pressure.

Key Dates

Start date
Feb 27, 2023
Status verified
Jul 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2027

Study Design

Enrollment
40 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Active SASm
    Patients will receive active treatment with the device every other day over 8 weeks.

Primary Outcome Measure

Change from baseline in visual field assessed by Humphrey Visual Field Index (VFI). [ Time Frame: Baseline through 6 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
Byers Eye InstitutePalo AltoCalifornia94303
Study Team
[email protected]
650-497-5942

Find similar trials in Palo Alto, CA

By condition
Glaucoma
By specialty
Ophthalmology
By research site
Byers Eye Institute· Palo Alto, CA

Related Studies